Oicintra Valuation
Is OICT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OICT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate OICT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate OICT's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OICT?
Key metric: As OICT is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is OICT's PB Ratio? | |
|---|---|
| PB Ratio | n/a |
| Book | US$24.00 |
| Market Cap | US$5.63b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does OICT's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.8x | ||
FG F&G Annuities & Life | 1.4x | 122.1% | US$5.9b |
LNC Lincoln National | 0.7x | 19.2% | US$5.9b |
OSCR Oscar Health | 3.4x | 68.7% | US$4.0b |
CNO CNO Financial Group | 1.5x | 12.4% | US$4.1b |
OICT Oicintra | n/a | n/a | US$5.6b |
Price-To-Book vs Peers: Insufficient data to calculate OICT's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Book Ratio vs Industry
How does OICT's PB Ratio compare vs other companies in the US Insurance Industry?
| 5 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 5 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: Insufficient data to calculate OICT's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is OICT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate OICT's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
China Life Insurance
HK$796.1b
Operates as a life insurance company in the People’s Republic of China.
LFCH.Y
HK$6.21
7D
3.0%
1Y
-30.1%
Sagicor Financial
CA$872.8m
Provides insurance products and related financial services in Jamaica, Barbados, Trinidad, Tobago, other Caribbean region, and the United States.
SGCF.F
CA$4.46
7D
0%
1Y
n/a
Aviva
UK£12.9b
Provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally.
AVVI.Y
UK£12.34
7D
-0.6%
1Y
13.4%